Once-Daily Aminoglycosides in Patients with Neutropenic Fever

The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med. 1993; 119(7 pt 1): 584–593.

Hughes W.T. , Armstrong D. , Bodey G.P. . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002; 34: 730–751.

Preston S.L. , Briceland L.L. . Single daily dosing of aminoglycosides. Pharmacotherapy. 1995; 15: 297–316.

Rice D.A.K. . Once daily aminoglycosides. Clin Trends Pharm Pract. 1996; 10: 9–15.

Freeman C.D. , Nicolau D.P. , Belliveau P.P. . Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Amtimicrob Chemother. 1997; 39: 677–686.

McDonald P.J. , Wetherall B.L. , Pruul H. . Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes. Rev Infect Dis. 1981; 3: 38–44.

Gibson J. , Johnson L. , Snowdon L. . Single daily ceftriaxone and tobramycin in the empirical management of febrile neutropenic patients: a randomised trial. Int J Hematol. 1993; 58: 63–72.

Rozdzinski E. , Kern W. , Reichle A. . Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients. J Antimicrob Chemother. 1993; 31: 585–598.

Hansen M. , Achen F. , Carstensen C. . Once- versus thrice-daily dosing of netilmicin in febrile immunocompromised patients: a randomized, controlled study of efficacy and safety. Journal of Drug Development. 1988; 1(suppl 3): 119–124.

Bakri F.E. , Pallett A. , Smith A.G. . Once-daily versus multiple-daily gentamicin in empirical antibiotic therapy of febrile neutropenia following intensive chemotherapy. J Antimicrob Chemother. 2000; 45: 383–386.

Charnas R. , Luthi A.R. , Ruch W. . Once daily ceftriaxone plus amikacin vs three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Pediatr Infect Dis J. 1997; 16: 346–353.

MacArthur R.D. , Lolans V. , Zar F.A. . Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic. J Infect Dis. 1984; 150: 778–779.

Moore R.D. , Smith C.R. , Lietman P.S. . The association of aminoglycoside plasma levels with mortality in patients with gramnegative bacteremia. J Infect Dis. 1984; 149: 443–448.

Dudley M.N. , Zinner S.H. . Single daily dosing of amikacin in an in vitro model. J Antimicrob Chemo. 1991; 27(suppl C): 15–19.

Begg E.J. , Peddie B.A. , Chambers S.T. . Comparison of gentamicin dosing regimens using an in-vitro model. J Antimicrob Chemother. 1992; 29: 427–433.

Blaser J. , Stone B.B. , Groner M.C. . Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother. 1987; 31: 1054–1060.

Moore R.D. , Lietman P.S. , Smith C.R. . Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987; 155: 93–99.

Ericsson C.D. , Fischer R.P. , Rowlands B.J. . Prophylactic antibiotics in trauma: the hazards of underdosing. J Trauma. 1989; 29: 1356–1361.

Verpooten G.A. , Giuliano R.A. , Verbist L. . Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharmacol Ther. 1989; 45: 22–27.

Nicolau D.P. , Freeman C.D. , Belliveau P.P. . Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995; 39: 650–655.

Ali M.Z. , Goetz M.B. . A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997; 24: 796–809.

Bailey T.C. , Little J.R. , Littenberg B. . A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997; 24: 786–795.

Ferriols-Lisart R. , Alos-Alminana M. . Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Am J Health Syst Pharm. 1996; 53: 1141–1150.

Hatala R. , Dinh T. , Cook D.J. . Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med. 1996; 124: 717–725.

Munckhof W.J. , Grayson M.L. , Turnidge J.D. . A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother. 1996; 37: 645–663.

Barza M. , Ioannidis J.P. , Cappelleri J.C. . Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ. 1996; 312: 338–345.

Blaser J. , Konig C. . Once-daily dosing of aminoglycosides. Eur J Clin Microbiol Infect Dis. 1995; 14: 1029–1038.

Galloe A.M. , Graudal N. , Christensen H.R. . Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur J Clin Pharmacol. 1995; 48: 39–43.

Brummett R.E. , Fox K.E. . Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother. 1989; 33: 797–800.

Kibbler C.C. , McWhinney P.H. , Warner P. . Ototoxicity associated with a once daily dose amikacin regimen in febrile neutropenic patients. J Antimicrob Chemother. 1992; 29: 463–464.

Tran Ba Huy P. , Deffrennes D. . Aminoglycoside ototoxicity: influence of dosage regimen on drug uptake and correlation between membrane binding and some clinical features. Acta Otolaryngol. 1988; 105: 511–515.

Warkentin D. , Ippoliti C. , Bruton J. . Toxicity of single daily dose gentamicin in stem cell transplantation. Bone Marrow Transplant. 1999; 24: 57–61.

Craig W.A. . Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J Antimicrob Chemother. 1993; 31(suppl D): 149–158.

Spivey J.M. . The postantibiotic effect. Clin Pharm. 1992; 11: 876–877.

Karlowsky J.A. , Zelenitsky S.A. , Zhanel G.G. . Aminoglycoside adaptive resistance. Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model. Pharmacotherapy. 1997; 17: 549–555.

Lacy M.K. , Nicolau D.P. , Nightingale C.H. . The pharmacodynamics of aminoglycosides. Clin Infect Dis. 1998; 2723–27.

Craig W.A. . Once-daily versus multiple-daily dosing of aminoglycosides. J Chemother. 1995; 7(suppl 2): 47–52.

Daikos G.L. , Jackson G.G. , Lolans V.T. . Adaptive resistance to aminoglycosides antibiotics from first-exposure down-regulation. J Infect Dis. 1990; 162: 414–420.

Daikos G.L. , Lolans V.T. , Jackson G.G. . First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother. 1991; 35: 117–123.

Rapoport B.L. , Sussmann O. , Herrera M.V. . Ceftriaxone plus once daily aminoglycoside with filgrastim for treatment of febrile neutropenia: early hospital discharge vs standard in-patient care. Chemotherapy. 1999; 45: 466–476.

Nicolau D.P. , Wu A.H. , Finocchiaro S. . Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. Ther Drug Monit. 1996; 18: 263–266.

Cornely O.A. , Bethe U. , Salzberger B. . Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever. Ann Hematol. 2001; 80: 103–108.

Gilbert C. , Meisenberg B. , Vredenburgh J. . Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. J Clin Oncol. 1994; 12: 1005–1011.

Cooke R.P. , Grace R.J. , Gover P.A. . Audit of once-daily dosing gentamicin therapy in neutropenic fever. Int J Clin Pract. 1997; 51: 229–231.

Hatala R. , Dinh T.T. , Cook D.J. . Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin Infect Dis. 1997; 24: 810–815.

Nicolau D. , Quintiliani R. , Nightingale C.H. . Once-daily aminoglycosides. Conn Med. 1992; 56: 561–563.

Van der Auwera P. , Meunier F. , Ibrahim S. . Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection. Antimicrob Agent Chemother. 1991; 35: 640–647.